- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07566871
Effect of Non-Invasive Vagus Nerve Stimulation in Burn Patients
The Effect of Non-Invasive Vagus Nerve Stimulation on Anxiety, Sleep Quality, Pain, Itching, and Autonomic Function in Burn Patients
This study will evaluate the effects of non-invasive vagus nerve stimulation (nVNS) in adults with burn injuries. Burn patients may experience anxiety, poor sleep quality, pain, itching, and changes in autonomic nervous system function during recovery.
Participants will be randomly assigned to one of two groups. The intervention group will receive conventional physiotherapy plus nVNS, and the control group will receive conventional physiotherapy only. Both groups will receive treatment 5 days per week for a total of 10 sessions. nVNS will be applied through electrodes placed on the external ear for 20 minutes per session.
Anxiety, sleep quality, pain, itching, and autonomic function will be assessed before and after the treatment period. Autonomic function will be evaluated using heart rate variability measurements. The results will help determine whether nVNS may be a useful supportive method in the rehabilitation of burn patients.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
This study is a randomized controlled experimental study designed to investigate the effects of non-invasive vagus nerve stimulation (nVNS) on anxiety, sleep quality, pain, itching, and autonomic nervous system function in adults with burn injuries.
The study population will consist of patients followed at the Burn Outpatient Clinic of Kartal Dr. Lütfi Kırdar City Hospital in Istanbul, Türkiye. Eligible participants will be adults aged 18 to 65 years who have completed the acute phase of burn injury, whose burn injury occurred between 1 month and 1 year before enrollment, and who have second- or third-degree burns involving 5% to 30% of total body surface area. Participants must also report at least one complaint related to anxiety, sleep quality, pain, or itching and provide written informed consent.
A total of 60 participants are planned to be included. Participants will be randomly assigned in equal numbers to an intervention group or a control group. The intervention group will receive conventional physiotherapy and nVNS. The control group will receive conventional physiotherapy only. Both groups will receive treatment 5 days per week for a total of 10 sessions. Conventional physiotherapy will be planned according to each participant's needs and may include strengthening exercises, stretching exercises, balance exercises, active and passive range-of-motion exercises, and interventions for edema. Each conventional physiotherapy session will last approximately 45 minutes.
In the intervention group, nVNS will be applied using electrodes positioned on the tragus and the anterior and posterior surfaces of the concha of the right and left external ear. Stimulation will be delivered continuously for 20 minutes with a biphasic asymmetric waveform, a pulse duration of 300 microseconds, and a frequency of 25 Hz. The stimulation intensity will be increased in 0.1 mA steps until the sensory threshold is reached. If a participant feels unwell during stimulation, the procedure will be stopped.
Outcome assessments will be performed before treatment and after completion of the 10th session. Anxiety will be assessed using the Beck Anxiety Inventory. Sleep quality will be assessed using the Pittsburgh Sleep Quality Index. Pain will be assessed using a visual analog scale. Itching severity will be assessed using the 12-Item Pruritus Severity Scale. Autonomic nervous system function will be evaluated using heart rate variability measurements recorded with a Polar H10 heart rate sensor and analyzed with Kubios HRV software.
The study aims to determine whether adding nVNS to conventional physiotherapy provides additional benefits for psychological symptoms, sleep quality, pain, itching, and autonomic function in burn rehabilitation.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Kartal
-
Istanbul, Kartal, Turquie (Türkiye), 34865
- Kartal Dr. Lütfi Kırdar City Hospital Burn Unit
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Adults aged 18 to 65 years
- Patients who have completed the acute phase of burn injury
- Burn injury occurred at least 1 month and no more than 1 year before enrollment
- Second- or third-degree burn involving 5% to 30% of total body surface area
- Presence of at least one complaint related to anxiety, sleep quality, pain, or itching
- Able to read and understand Turkish
- Willing to participate in the study
- Written informed consent provided
Exclusion Criteria:
- Infection, ulcer, or scar tissue on the auricle
- Burn injury in the head and neck region preventing application of the device over the auricular branch of the vagus nerve
- Metallic implant in the skull
- Excessive sensitivity, injury, or inflammation in the ear
- Chronic pulmonary disease and/or chronic cardiac disease
- Resting heart rate below 60 beats per minute
- Presence of a pacemaker, cochlear implant, or similar implanted device
- Uncontrolled hypertension
- Lack of cooperation or inability to comply with study procedures
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Conventional Physiotherapy Plus Non-Invasive Vagus Nerve Stimulation
Participants in this group will receive conventional physiotherapy plus non-invasive vagus nerve stimulation.
Treatment will be provided 5 days per week for a total of 10 sessions.
Conventional physiotherapy will last approximately 45 minutes per session.
Non-invasive vagus nerve stimulation will be applied to the external ear for 20 minutes per session.
|
Non-invasive vagus nerve stimulation will be applied using a Vagustim device.
Electrodes will be placed on the tragus and the anterior and posterior surfaces of the concha of both ears.
Stimulation will be applied continuously for 20 minutes per session with a biphasic asymmetric waveform, a pulse duration of 300 microseconds, and a frequency of 25 Hz.
Stimulation intensity will be increased in 0.1 mA steps until the sensory threshold is reached.
The procedure will be stopped if the participant feels unwell.
Conventional physiotherapy will be planned according to each participant's needs and will be provided by a physiotherapist.
The program may include strengthening exercises, stretching exercises, balance exercises, active and passive range-of-motion exercises, and interventions for edema.
Sessions will be performed 5 days per week for a total of 10 sessions, with each session lasting approximately 45 minutes.
|
|
Comparateur actif: Conventional Physiotherapy
Participants in this group will receive conventional physiotherapy only.
Treatment will be provided 5 days per week for a total of 10 sessions.
Conventional physiotherapy will be planned according to each participant's needs and may include strengthening exercises, stretching exercises, balance exercises, active and passive range-of-motion exercises, and interventions for edema.
|
Conventional physiotherapy will be planned according to each participant's needs and will be provided by a physiotherapist.
The program may include strengthening exercises, stretching exercises, balance exercises, active and passive range-of-motion exercises, and interventions for edema.
Sessions will be performed 5 days per week for a total of 10 sessions, with each session lasting approximately 45 minutes.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Anxiety Level
Délai: Baseline and after completion of 10 treatment sessions, up to 2 weeks
|
Anxiety level will be assessed using the Beck Anxiety Inventory.
The scale includes 21 items scored from 0 to 3, with a total score ranging from 0 to 63.
Higher scores indicate greater anxiety severity.
|
Baseline and after completion of 10 treatment sessions, up to 2 weeks
|
|
Change in Sleep Quality
Délai: Baseline and after completion of 10 treatment sessions, up to 2 weeks
|
Sleep quality will be assessed using the Pittsburgh Sleep Quality Index.
The scale evaluates sleep quality and sleep disturbances over the previous month.
The total score ranges from 0 to 21, and higher scores indicate poorer sleep quality.
|
Baseline and after completion of 10 treatment sessions, up to 2 weeks
|
|
Change in Pain Intensity
Délai: Baseline and after completion of 10 treatment sessions, up to 2 weeks
|
Pain intensity will be assessed using a visual analog scale.
Participants will mark their pain level on a 100-mm line, where higher scores indicate greater pain intensity.
|
Baseline and after completion of 10 treatment sessions, up to 2 weeks
|
|
Change in Pruritus Severity
Délai: Baseline and after completion of 10 treatment sessions, up to 2 weeks
|
Pruritus severity will be assessed using the 12-Item Pruritus Severity Scale.
The scale evaluates multiple aspects of itching, including location, duration, frequency, intensity, scratching behavior, emotional effects, sleep disturbance, daily activity effects, and quality-of-life impact.
Higher scores indicate more severe itching.
|
Baseline and after completion of 10 treatment sessions, up to 2 weeks
|
|
Change in Root Mean Square of Successive Differences
Délai: Baseline and after completion of 10 treatment sessions, up to 2 weeks
|
Autonomic nervous system function will be assessed using the root mean square of successive differences between normal RR intervals derived from heart rate variability analysis.
RR interval data will be recorded with a Polar H10 heart rate sensor during a 5-minute resting measurement and analyzed using Kubios HRV software.
The root mean square of successive differences will be reported in milliseconds.
|
Baseline and after completion of 10 treatment sessions, up to 2 weeks
|
|
Change in Standard Deviation of Normal-to-Normal Intervals
Délai: Baseline and after completion of 10 treatment sessions, up to 2 weeks
|
Autonomic nervous system function will be assessed using the standard deviation of normal-to-normal intervals derived from heart rate variability analysis.
RR interval data will be recorded with a Polar H10 heart rate sensor during a 5-minute resting measurement and analyzed using Kubios HRV software.
The standard deviation of normal-to-normal intervals will be reported in milliseconds.
|
Baseline and after completion of 10 treatment sessions, up to 2 weeks
|
|
Change in Low-Frequency/High-Frequency Ratio
Délai: Baseline and after completion of 10 treatment sessions, up to 2 weeks
|
Autonomic nervous system function will be assessed using the low-frequency/high-frequency ratio derived from heart rate variability analysis.
RR interval data will be recorded with a Polar H10 heart rate sensor during a 5-minute resting measurement and analyzed using Kubios HRV software.
The low-frequency/high-frequency ratio will be reported as a ratio.
|
Baseline and after completion of 10 treatment sessions, up to 2 weeks
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Sümeyye Akçay, Asst. Prof., Fenerbahçe University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Manifestations neurologiques
- Maladies du système nerveux
- Les troubles mentaux
- Blessures et Blessures
- Manifestations cutanées
- Troubles du sommeil et de l'éveil
- Maladies de la peau
- Troubles du sommeil, intrinsèques
- Dyssomnies
- Conditions pathologiques, signes et symptômes
- Maladies de la peau et du tissu conjonctif
- Signes et symptômes
- La douleur
- Troubles anxieux
- Troubles de l'initiation et du maintien du sommeil
- Brûlures
- Prurit
Autres numéros d'identification d'étude
- KartalHosp
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Brûlure
-
Seoul National University HospitalMind Works Clinical Psychologist GroupPas encore de recrutement
-
Cairo UniversityComplétéBrûlures | Cicatrice hypertrophique | Burn Scar (post-brûler)Egypte
-
Chinese University of Hong KongCity University of Hong KongComplétéStress (Psychologie) | Burn Out (Psychologie)Hong Kong
-
Sheba Medical CenterInconnue
-
Saint-Louis Hospital, Paris, FranceComplétéPrévalence du burn-out chez les professionnels des soins intensifsBelgique
-
Cukurova UniversityComplétéMéditation de Pleine Conscience | Burn Out (Psychologie) | Auto-compassionTurquie
-
University Hospital, MontpellierComplétéSimulation | Qualité de la vie professionnelle | Burn-outFrance
-
University of North Carolina, Chapel HillComplétéBurnout | Stress lié au travail | Burn Out (Psychologie)États-Unis
-
Medical University of GrazRecrutementDépression | Dormir | Stress psychologique | Qualité nutritionnelle | Syndrome de burn-outL'Autriche
-
Kessler FoundationInstituto Vocacional Enrique Díaz de León A.C., Guadalajara, MexicoRecrutementTBI (Traumatic Brain Injury) ou MS (Sclérose en Plaques)États-Unis, Espagne
Essais cliniques sur Non-Invasive Vagus Nerve Stimulation
-
Cairo UniversityComplétéObésité | Pression artérielleEgypte
-
Northwell HealthToshiba America Medical Systems, Inc.Inscription sur invitationMaladie de l'artère coronaire | Douleur thoracique | Syndrome coronarien aigu | Infarctus aigu du myocardeÉtats-Unis
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinComplété
-
Cynosure, Inc.Résilié
-
Tampere University HospitalComplétéArythmies cardiaques | Pression artérielleFinlande
-
Northwell HealthHeartFlow, Inc.ComplétéAngine de poitrine, douleur thoracique stable
-
University of ManitobaPas encore de recrutementInsuffisance cardiaqueCanada
-
University Hospital, MontpellierComplétéDiagnostic prénatal non invasifFrance
-
The Rogosin InstituteOutset Medical; CareTaker Medical LLCComplétéPhase terminale de la maladie rénale | Insuffisance rénale en phase terminale sous dialyse | Dialyse Hypotension | Hypertension induite par la dialyseÉtats-Unis
-
University Hospital TuebingenComplétéNéoplasie cervicale intraépithéliale IIIAllemagne